U.S. markets open in 6 hours 9 minutes
  • S&P Futures

    3,968.75
    +6.75 (+0.17%)
     
  • Dow Futures

    33,911.00
    +54.00 (+0.16%)
     
  • Nasdaq Futures

    11,546.00
    +21.25 (+0.18%)
     
  • Russell 2000 Futures

    1,841.50
    +3.70 (+0.20%)
     
  • Crude Oil

    78.84
    +0.64 (+0.82%)
     
  • Gold

    1,769.00
    +5.30 (+0.30%)
     
  • Silver

    21.50
    +0.06 (+0.28%)
     
  • EUR/USD

    1.0351
    +0.0016 (+0.16%)
     
  • 10-Yr Bond

    3.7480
    0.0000 (0.00%)
     
  • Vix

    21.89
    -0.32 (-1.44%)
     
  • GBP/USD

    1.1965
    +0.0015 (+0.12%)
     
  • USD/JPY

    138.7240
    +0.0900 (+0.06%)
     
  • BTC-USD

    16,908.08
    +465.72 (+2.83%)
     
  • CMC Crypto 200

    401.88
    +13.15 (+3.38%)
     
  • FTSE 100

    7,549.55
    +37.55 (+0.50%)
     
  • Nikkei 225

    27,968.99
    -58.85 (-0.21%)
     

Calithera's stock is up 14% after announcing Fast Track designation for lung-cancer drug candidate

Calithera's stock is up 14% after announcing Fast Track designation for lung-cancer drug candidate

Shares of Calithera Biosciences Inc. jumped 14.6% in premarket trading on Monday after the company said it received a Fast Track designation for its experimental treatment for non-small cell lung cancer. The drug is currently being tested in Phase 2 clinical trial. Calithera's stock has tumbled 77.9% so far this year, while the S&P 500 has declined 24.7%.